维多珠单抗在老年炎症性肠病患者中安全有效。 - Suppr

Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.

作者信息

Navaneethan Udayakumar, Edminister Timothy, Zhu Xiang, Kommaraju Kiran, Glover Sarah

机构信息

*IBD Center, Center for Interventional Endoscopy, Florida Hospital, Orlando, Florida †Department of Gastroenterology, University of Florida, Gainesville, Florida.

出版信息

Inflamm Bowel Dis. 2017 Apr;23(4):E17. doi: 10.1097/MIB.0000000000001071.

DOI:10.1097/MIB.0000000000001071

PMID:28296827

Abstract

摘要

相似文献

Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.

Inflamm Bowel Dis. 2017 Apr;23(4):E17. doi: 10.1097/MIB.0000000000001071.

Vedolizumab is safe and effective in moderate-to-severe inflammatory bowel disease following liver transplantation.

Liver Transpl. 2017 Jul;23(7):968-971. doi: 10.1002/lt.24757.

Efficacy of Vedolizumab for Inflammatory Bowel Disease in the Setting of DiGeorge Syndrome.

J Pediatr Gastroenterol Nutr. 2019 May;68(5):e88. doi: 10.1097/MPG.0000000000002322.

Blocking α4β7 Integrin Through Vedolizumab: Necessary but not Sufficient?

J Crohns Colitis. 2017 Aug 1;11(8):903-904. doi: 10.1093/ecco-jcc/jjx033.

Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease.

Gastroenterology. 2018 Feb;154(3):752-754.e1. doi: 10.1053/j.gastro.2017.08.067. Epub 2017 Oct 5.

Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease.

Clin Rheumatol. 2019 Feb;38(2):609-610. doi: 10.1007/s10067-018-4357-y. Epub 2018 Nov 5.

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease.

Dig Dis Sci. 2018 Apr;63(4):825-833. doi: 10.1007/s10620-018-4971-1. Epub 2018 Feb 26.

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease.

Clin Gastroenterol Hepatol. 2016 Nov;14(11):1593-1601.e2. doi: 10.1016/j.cgh.2016.02.016. Epub 2016 Feb 22.

A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study.

Dig Liver Dis. 2018 Dec;50(12):1299-1304. doi: 10.1016/j.dld.2018.07.007. Epub 2018 Jul 18.

Designing biologic selectivity for inflammatory bowel disease--role of vedolizumab.

Drug Des Devel Ther. 2014 Dec 17;9:147-54. doi: 10.2147/DDDT.S50348. eCollection 2015.

引用本文的文献

Vedolizumab subcutaneous formulation maintenance therapy for patients with IBD: a systematic review and meta-analysis.

Therap Adv Gastroenterol. 2023 Apr 27;16:17562848231166227. doi: 10.1177/17562848231166227. eCollection 2023.

Vedolizumab Is Safe in Elderly Veteran Patients With Inflammatory Bowel Disease.

Crohns Colitis 360. 2021 Jun 16;3(3):otab025. doi: 10.1093/crocol/otab025. eCollection 2021 Jul.

Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management.

Cancers (Basel). 2023 Jan 31;15(3):871. doi: 10.3390/cancers15030871.

How to Choose the Biologic Therapy in a Bio-naïve Patient with Inflammatory Bowel Disease.

J Clin Med. 2022 Feb 4;11(3):829. doi: 10.3390/jcm11030829.

Iatrogenic Kaposi's sarcoma unmasked by Vedolizumab in a patient with ulcerative colitis and well-controlled human immunodeficiency virus: A case report.

Int J Crit Illn Inj Sci. 2021 Jul-Sep;11(3):177-180. doi: 10.4103/IJCIIS.IJCIIS_92_20. Epub 2021 Sep 25.

Clinical characteristics of ulcerative colitis in elderly patients.

JGH Open. 2021 Jul 12;5(8):849-854. doi: 10.1002/jgh3.12612. eCollection 2021 Aug.

Vedolizumab in Inflammatory Bowel Disease: West versus East.

Inflamm Intest Dis. 2021 Feb;6(1):1-17. doi: 10.1159/000512805. Epub 2021 Jan 27.

Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements.

United European Gastroenterol J. 2021 Apr;9(3):398-406. doi: 10.1177/2050640620965106. Epub 2021 Feb 26.

How to manage IBD in the 'elderly'.

Frontline Gastroenterol. 2019 Nov 15;11(6):468-477. doi: 10.1136/flgastro-2019-101218. eCollection 2020 Oct.

Efficacy and safety of vedolizumab in elderly patients with inflammatory bowel disease: a matched case-control study.

Gastroenterol Rep (Oxf). 2019 Sep 17;8(4):306-311. doi: 10.1093/gastro/goz041. eCollection 2020 Aug.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.

作者信息

Navaneethan Udayakumar, Edminister Timothy, Zhu Xiang, Kommaraju Kiran, Glover Sarah

机构信息

*IBD Center, Center for Interventional Endoscopy, Florida Hospital, Orlando, Florida †Department of Gastroenterology, University of Florida, Gainesville, Florida.

出版信息

Inflamm Bowel Dis. 2017 Apr;23(4):E17. doi: 10.1097/MIB.0000000000001071.

DOI:10.1097/MIB.0000000000001071

PMID:28296827

Abstract

摘要

相似文献

Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.

Inflamm Bowel Dis. 2017 Apr;23(4):E17. doi: 10.1097/MIB.0000000000001071.

Vedolizumab is safe and effective in moderate-to-severe inflammatory bowel disease following liver transplantation.

Liver Transpl. 2017 Jul;23(7):968-971. doi: 10.1002/lt.24757.

Efficacy of Vedolizumab for Inflammatory Bowel Disease in the Setting of DiGeorge Syndrome.

J Pediatr Gastroenterol Nutr. 2019 May;68(5):e88. doi: 10.1097/MPG.0000000000002322.

Blocking α4β7 Integrin Through Vedolizumab: Necessary but not Sufficient?

J Crohns Colitis. 2017 Aug 1;11(8):903-904. doi: 10.1093/ecco-jcc/jjx033.

Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease.

Gastroenterology. 2018 Feb;154(3):752-754.e1. doi: 10.1053/j.gastro.2017.08.067. Epub 2017 Oct 5.

Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease.

Clin Rheumatol. 2019 Feb;38(2):609-610. doi: 10.1007/s10067-018-4357-y. Epub 2018 Nov 5.

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease.

Dig Dis Sci. 2018 Apr;63(4):825-833. doi: 10.1007/s10620-018-4971-1. Epub 2018 Feb 26.

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease.

Clin Gastroenterol Hepatol. 2016 Nov;14(11):1593-1601.e2. doi: 10.1016/j.cgh.2016.02.016. Epub 2016 Feb 22.

A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study.

Dig Liver Dis. 2018 Dec;50(12):1299-1304. doi: 10.1016/j.dld.2018.07.007. Epub 2018 Jul 18.

Designing biologic selectivity for inflammatory bowel disease--role of vedolizumab.

Drug Des Devel Ther. 2014 Dec 17;9:147-54. doi: 10.2147/DDDT.S50348. eCollection 2015.

引用本文的文献

Vedolizumab subcutaneous formulation maintenance therapy for patients with IBD: a systematic review and meta-analysis.

Therap Adv Gastroenterol. 2023 Apr 27;16:17562848231166227. doi: 10.1177/17562848231166227. eCollection 2023.

Vedolizumab Is Safe in Elderly Veteran Patients With Inflammatory Bowel Disease.

Crohns Colitis 360. 2021 Jun 16;3(3):otab025. doi: 10.1093/crocol/otab025. eCollection 2021 Jul.

Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management.

Cancers (Basel). 2023 Jan 31;15(3):871. doi: 10.3390/cancers15030871.

How to Choose the Biologic Therapy in a Bio-naïve Patient with Inflammatory Bowel Disease.

J Clin Med. 2022 Feb 4;11(3):829. doi: 10.3390/jcm11030829.

Iatrogenic Kaposi's sarcoma unmasked by Vedolizumab in a patient with ulcerative colitis and well-controlled human immunodeficiency virus: A case report.

Int J Crit Illn Inj Sci. 2021 Jul-Sep;11(3):177-180. doi: 10.4103/IJCIIS.IJCIIS_92_20. Epub 2021 Sep 25.

Clinical characteristics of ulcerative colitis in elderly patients.

JGH Open. 2021 Jul 12;5(8):849-854. doi: 10.1002/jgh3.12612. eCollection 2021 Aug.

Vedolizumab in Inflammatory Bowel Disease: West versus East.

Inflamm Intest Dis. 2021 Feb;6(1):1-17. doi: 10.1159/000512805. Epub 2021 Jan 27.

Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements.

United European Gastroenterol J. 2021 Apr;9(3):398-406. doi: 10.1177/2050640620965106. Epub 2021 Feb 26.

How to manage IBD in the 'elderly'.

Frontline Gastroenterol. 2019 Nov 15;11(6):468-477. doi: 10.1136/flgastro-2019-101218. eCollection 2020 Oct.

Efficacy and safety of vedolizumab in elderly patients with inflammatory bowel disease: a matched case-control study.

Gastroenterol Rep (Oxf). 2019 Sep 17;8(4):306-311. doi: 10.1093/gastro/goz041. eCollection 2020 Aug.

Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.

作者信息

机构信息

出版信息

相似文献

引用本文的文献